Abstract
The usual methods for determining antibiotic activity, either alone or in combination, generally expose a growing bacterial inoculum to a constant or static concentration of one or more drugs for a period of approximately 20 h. Such methods include disk susceptibility tests, determinations of minimal inhibitory and minimal bactericidal concentrations with microtiter or macrotube dilutions and time-kill studies (34). Even the determination of serum bactericidal activity in patients or volunteers receiving a given antibiotic regimen only ascertains the antibiotic activity at a specific time, at a single concentration of drug or drugs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
M.J.S. Al-asadi, D. Greenwood and F. O’Grady: In vitro model simulating the form of exposure of bacteria to antimicrobial drugs encountered in infection. Antimicrob. Agents Chemother. 16, 77–80 (1979).
J.D. Anderson, K.R. Johnson and M.Y. Aird: Comparison of amoxicillin and ampicillin activities in a continuous culture model of human urinary bladder. Antimicrob. Agents Chemother. 17, 554–557 (1980).
A. Bauernfeind, R. Jungwirth and C. Petermüller: Simultaneous simulation of the serum profiles of two antibiotics and analysis of the combined effect against a culture of Pseudomonas aeruginosa. Chemotherapy 28, 334–340 (1982).
T. Bergan and I.B. Carlse: Effect of antibiotics eliminated by first order kinetics. J. antimicrob. Chemother. 15 (Suppl. A), 147–152 (1985).
J. Blaser, H. Rieder, P. Niederer and R. Lüthy: Biological variability of multiple dose pharmacokinetics of netilmicin in man. Eur. J. clin. Pharmac. 24,399–406(1983).
J. Blaser, B.B. Stone, D.H. Gilbert and S.H. Zinner: The effect of single and multiple doses of azlocillin and netilmicin in a pharmacokinetic model compared to standard in vitro methods. Proceedings of the 14th International Congress of Chemotherapy. In: J. Ishigami (Ed.) Recent Advances in Chemotherapy, Antimicrobial Section: 690–1 (1985).
J. Blaser, B.B. Stone, M.C. Groner and S.H. Zinner: Comparison of in vitro synergism testing with a pharmacokinetic model, checkerboard and killing curve methods. Program and Abstracts of the 25th Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract 1001. American Society for Microbiology, Washington 1985.
J. Blaser, B.B. Stone and S.H. Zinner: Efficacy of intermittent versus continuous administration of netilmicin in a two compartment in vitro model. Antimicrob. Agents Chemother. 27, 343–349 (1985).
J. Blaser, B.B. Stone, M.C. Groner and S.H. Zinner: Impact of netilmicin regimens on the acitivity of ceftazidime-netilmicin combinations against Pseudomonas aeruginosa in an in vitro pharmacokinetic model. Antimicrob. Agents Chemother. 28, 64–68 (1985).
J. Blaser : In vitro model for simultaneous simulation of the serum kinetics of two drugs with different half-lives. J. antimicrob. Chemother. 15(Suppl. A), 125–130(1985).
J. Blaser, B.B. Stone and S.H. Zinner: Two compartment kinetic model with multiple artificial capillary units. J. antimicrob. Chemother. 15 (Suppl. A), 131–137 (1985).
J. Blaser, D. Gilbert and S.H. Zinner: Effect of enoxacin with and without leukocytes against Staphylococcus aureus in a pharmacokinetic model. Rev. infect. Dis. (1987)in press.
J. Blaser, B.B. Stone, M.C. Groner and S.H. Zinner: Effect of the ratio of antibiotic peak concentration to MIC on bactericidal activity and emergence of restistance: a comparative study with enoxacin and netilmicin in a pharmacodynamic model. Antimicrob. Agents Chemother 31, 1054–60 (1987).
J. Blaser, O. Weinmann and R. Lüthy. Bacterial adhesion influences the in vitro assessment of bactericidal activity against Staphylococci. Program and Abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington 1987.
M.R.W. Brown: Nutrient depletion and antibiotic susceptibility. J. antimicrob. Chemother. 3, 198–201 (1977).
M.R.W. Brown and R Williams: Influence of substrate limitations and growth phase on sensitivity to antimicrobial agents. J. antimicrob. Chemother. 15 (Suppl. A), 7–14 (1985).
R.W. Bundtzen, A.U. Gerber, D.L. Cohn and W.A. Craig: Postantibiotic suppression of bacterial growth. Rev. infect. Dis. 3, 432–438 (1981).
V.M. Chernykh and A.A. Firsov: Kinetics of antimicrobial effect in dynamic model: Microcalorimetric recording and selection of parameters characterizing kinetic curves. Antibiot. med. Biotechnol. (USSR) 7, 498–503 (1985).
R.M. Cozens, E. Tuomanen, W. Tosch, O. Zak, J. Suter and A. Tomasz: Evaluation of the bactericidal activity of betalactam antibiotics on slowly growing bacteria cultured in the chemostat. Antimicrob. Agents Chemother. 29, 797–802 (1986).
M.N. Dudley, J. Blaser, M.J. Kuepker and S.H. Zinner: Evaluation of the significance of ‘extravascular’ protein binding of antimicrobials in an in vitro two compartment kinetic model. Program and Abstracts of the 25th Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract 559. American Society for Microbiology, Washington 1985.
M.N. Dudley, J. Blaser, D. Gilbert and S.H. Zinner: Bactericidal activity of ciprofloxacin against Pseudomonas aeruginosa and other bacteria in an in vitro two-compartment capillary model. Rev. infect. Dis. (1987).
European Organization for Research and Treatment of Cancer: Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. J. clin. Onc. 1, 597–603 (1983).
R. Feld, M. Valdiviesco, G.P. Bodey and V. Rodriquez: A comparative trial of sisomicin therapy by intermittent versus continuous infusion. Am. J. med. Sci. 274, 179–188 (1977).
A.A. Firsov, V.M. Chernykh, S.M. Kuznetsova and S.M. Navashin: Dynamic system for in vitro investigation of antimicrobial effect kinetics by simulating pharmacokinetic profiles of antibiotics. Antibiot. med. Biotechnol. (USSR) 30, 36–43 (1985).
A.U. Gerber, P. Wiprächtiger, U. Stettler-Spichiger and G. Lebek: Constant infusions vs. intermittent doses of gentamicin against Pseudomonas aeruginosa in vitro. J. infect. Dis. 145, 554–560 (1982).
A.U. Gerber, W.A. Craig, H.P. Brugger, C. Feller, A.P. Vastola and J. Brandel: Impact of dosing intervals on activity of gentamicin and ticarcillin against Pseudomonas aeruginosa in granulocytopenic mice. J. infect. Dis. 147, 910–917 (1983).
A.U. Gerber, H.P. Brugger, C. Feller, T. Strizko and B. Stalder: Antibiotic therapy of infections due to Pseudomonas aeruginosa in normal and granulocytopenic mice: Comparison of murine and human pharmacokinetics. J. infect. Dis. 153, 90–97 (1986).
S. Grasso, G. Meinardi, L. deCarneri and V. Tamassia: New in vitro model to study the effect of antibiotic concentration and rate of elimination on antibacterial activity. Antimicrob. Agents Chemother. 13, 570–576 (1978).
D. Greenwood and F. O’Grady: An in vitro model of the urinary bladder. J. antimicrob. Chemother. 4, 113–120 (1978).
D. Greenwood: An in vitro model simulating the hydrokinetic aspects of the treatment of bacterial cystitis. J. Antimicrob. Chemother. 15 (Suppl. A), 103–111 (1985).
R. Haag, P. Lexa and I. Werkhäuser. Artifacts in dilution pharmacokinetic models caused by adherent bacteria. Antimicrob. Agents Chemother. 29, 765–768 (1986).
I. Haller: Combined action of decreasing concentrations of azlocillin and sisomicin on Pseudomonas aeruginosa as assessed in a dynamic in vitro model. Infection 10 (Suppl. 3), 229–233 (1982).
J.G. Jemsek, R.R. Martin, S.B. Greenberg and L.O. Gentry: Antimicrobial susceptibility testing of Haemophilus parainfluenzae by a kinetic killing-curve method. J. infect. Dis. 141, 310–316 (1980).
B. Ledergerber, J. Blaser and R. Lüthy: Computer-controlled in vitro simulation of multiple dosing regimens. J. antimicrob. Chemother. (Suppl. 15A ), 169–175 (1985).
F. Leitner, R.A. Goodhines, R.E.Buck and K. E. Price: Bactericidal activitiy of Cefadroxil, cephalexin and cephradine in an in vitro pharmacokinetic model. J. Antibiotics 32, 718–726 (1979).
E.H. Lennette, A. Balows and W.J. Hausier and J. P. Traunt. Manual of clinical microbiology. 3rd ed. American Society for Microbiology, Washington 1980.
D. Lewis, D. Reeves, B. Widemann and S.H. Zinner: Methodology and evaluation of in vitro models of antimicrobial chemotherapy. J. antimicrob. Chemother. 15 (Suppl. A) 1985.
R.D. Moore, P.S. Lietman and R.S. Craig: Clinical response to aminoglycoside therapy: Importance of the ratio of peak concentration to minimal inhibitory concentration. J. infect. Dis. 155, 93–99 (1987).
J.E. McLaughlin and D.S. Reeves: Clinical and laboratory evidence for inactivation of gentamicin by carbenicillin. Lancet 1, 261–4 (1971).
T. Murakawa, H. Sakamoto, T. Hirose and M. Nishida: New in vitro model for evaluating bactericidal efficacy of antibiotics. Antimicrob. Agents Chemother. 18, 377–381 (1980).
M. Nishida, T. Murakawa, T. Kamimura and N. Okada: Bactericidal activity of cephalosporins in an in vitro model simulating serum levels. Antimicrob. Agents Chemother. 14, 6–12 (1978).
F. O’Grady and J.H. Pennington: Bacterial growth in an in vitro system simulating conditions in the urinary bladder. Br. J. exp. Path. 47, 152–157 (1966).
H. Otaya, A. Ozawa and J. Goto: Mode of action of chemotherapeutic agents against bacteria growing in a continuous flow culture with special reference to the antibacterial effect of cephalothin, erythromycin and kanamycin. In: Chemotherapy, pp. 205–210. Eds. J.D. Williams and A.M. Geddes. Plenum Press, New York 1976.
S.H. Powell, W.L. Thompson, M.A. Luthe, R.C. Stern, D.A. Grossniklaus et al. Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal studies of gentamicin, netilmicin, and tobramycin. J. infect. Dis. 147, 918–932 (1983).
J.A. Randolph, R.E. Buck, K.E. Price and F. Leitner: Comparative bactericidal effect of ceforanide (BL-S 786) and five other cephalosporins in an in vitro pharmacokinetic model. J. Antibiotics 31, 727–733 (1979).
D.S. Reeves: Advantages and disadvantages of an in vitro model with two compartments connected by a dialyser: results of experiments with ciprofloxacin. J. antimicrob. Chemother. 15 (Suppl. A), 159–169 (1985).
A. Sanfilippo and E. Morvillo: An experimental model for the study of the antibacterial activity of the sulfonamides. Chemotherapy 13, 54–60 (1968).
F. Schlaeffer, J. Blaser and S.H. Zinner: Enhancement of leukocyte killing of aminoglycoside and quinolone induced resistant bacterial subpopulations. Program and Abstracts of the 25th Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract 400. American Society for Microbiology, Washington 1985.
F. Schlaeffer, J. Laxon, J. Blaser and S.H. Zinner: Ciprofloxacin enhanced leukocyte killing of drug induced resistant bacteria. Rev. infect. Dis. (1987)in press.
R Schneider, W. Tosch, M. Maurer and O. Zak: Antibacterial effects of cefroxadine, cephalexin and cephradine in a new in vitro pharmacokinetic model. J. Antibiotics 35, 843–849 (1982).
A.H. Seeberg and B. Wiedemann: Application of in vitro models: development of resistance. J. antimicrob. Chemother. 15 (Suppl. A): 241–250 (1985).
P.M. Shah: Bactericidal activity of ampicillin and amoxicillin. J. antimicrob. Chemother. 8 (Suppl. C), 93–99 (1981).
P.M. Shah, K. Racky and W. Stille: In vitro Untersuchungen zum Dosierungsintervall von Cefoperazon. Arzneimittel-Forsch./Drug Res. 31, 482–485 (1981).
P.M. Shah: Activity of imipenem in an in vitro model simulating pharmacokinetic parameters in human blood. J. antimicrob. Chemother. 15 (Suppl. A), 153–158 (1985).
R.D. Toothaker, P.G. Welling and W.A. Craig: An in vitro model for the study of antibacterial dosage regimen design. J. pharm. Sci. 71, 861–864 (1982).
W. Tosch and R. Schnell: Possible approaches to the simulation of antibiotic kinetics and the determination of antibacterial activity in vitro. J. antimicrob. Chemother. 15 (Suppl. A), 117–120 (1985).
L.L. Van Etta, L.R. Peterson and D.N. Gerding: Effect of the ratio of surface area to volume on the penetration of antibiotics into extravascular spaces in an in vitro model. J. infect. Dis. 146, 423–428 (1982).
H. Walther and F.P. Meyer: Klinische Pharmokologie antimikrobieller Arzneimittel. Urban & Schwarzberg, München-Wien-Baltimore 1987.
C.A. White and R.D. Toothaker: Influence of ampicillin elimination half-life on in vitro bactericidal effect. J. antimicrob. Chemother. 15 (Suppl. A), 257–260 (1985).
A.R. White, D.H. Stokes, B. Slocombe and R. Sutherland: Bactericidal effects of amoxicillin/clavulanic acid and ticarcillin/clavulanic acid in in vitro kinetic models. J. antimicrob. Chemother. 15 (Suppl. A), 227–232 (1985).
M.C. Wiemann, J. Blaser, A. Hollmann and P. Calabrisi: An in vitro model for testing anticancer drugs. Clinical Research, 34, 572A (1986).
L. Xerri, P. Orsolini and R. Broggio: In vitro evaluation of ceftazidime (GR 20263), amikacin and sisomicin, in a model simulating serum pharmacokinetics of therapeutic doses. Chemioterapia 3, 271–277 (1984).
O. Zak and M. A. Sande: Correlation of in vitro antimicrobial activity of antibiotics with results of treatment in experimental animal models and human infection. In: Action of antibiotics in patients, Ed. L.D. Sabath, Hans Huber Publishers, Berne, Switzerland 1982.
S.H. Zinner, M. Husson and J. Klastersky: An artificial capillary in vitro model of antibiotic bactericidal activity. J. infect. Dis. 144, 583–587 (1980).
S.H. Zinner, H. Lagast and J. Klastersky: Antistaphylococcal activity of rifampicin with other antibiotics. J. infect. Dis. 144, 365–371 (1981).
S.H. Zinner and J. Blaser: Efficacy of DNA-gyrase inhibitors in experimental animal studies and in pharmacokinetic in vitro models. Res. clin. Forums 7,45–54(1985).
S.H. Zinner, J. Blaser, B.B. Stone and M.C. Groner: Use of in in vitro kinetic model to study antibiotic combinations. J. antimicrob. Chemother. 15 (Suppl. A), 221–226(1985).
S.H. Zinner and J. Blaser: In vitro studies of antibiotic combinations with special emphasis on the evaluation of newly developed methods. J. antimicrob. Chemother. 17 (Suppl. A), 1–5 (1986).
S.H. Zinner, J. Blaser and H. Gaya: Laboratory support for choosing and monitoring antimicrobial therapy in severely ill patients. Am. J. Med. 80 (Suppl. 5C), 59–63 (1986).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Birkhäuser Verlag Basel
About this chapter
Cite this chapter
Blaser, J., Zinner, S.H. (1987). In Vitro Models for the Study of Antibiotic Activities. In: Jucker, E., Meyer, U. (eds) Progress in Drug Research/Fortschritte der Arzneimittelforschung/Progrès des recherches pharmaceutiques. Progress in Drug Research/Fortschritte der Arzneimittelforschung/Progrès des recherches pharmaceutiques, vol 31. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-9289-6_11
Download citation
DOI: https://doi.org/10.1007/978-3-0348-9289-6_11
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-0348-9981-9
Online ISBN: 978-3-0348-9289-6
eBook Packages: Springer Book Archive